Related Experiment Video
Updated: Aug 17, 2026
10:47
Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface
Published on: February 21, 2011
Particulate matter of smoke inhalation
1London Hospital Medical College, UK.
Annals of the Academy of Medicine, Singapore
|January 1, 1993
Summary
Smoke inhalation injury, often complicating burns, increases mortality. Lung damage from inhaled particles and toxic gases triggers inflammation, potentially causing long-term respiratory issues.
Area of Science:
- Medicine
- Toxicology
- Pulmonology
Background:
- Smoke inhalation injury frequently complicates cutaneous burns, significantly increasing mortality.
- Facial burns are particularly associated with a higher risk of smoke inhalation injury.
- Upper airway thermal injury is primarily caused by heat, typically not extending past the tracheal bifurcation.
Purpose of the Study:
- To elucidate the mechanisms of lung injury following smoke inhalation.
- To understand the role of particulate matter and toxic gases in respiratory damage.
- To investigate the inflammatory response and its feedback mechanisms in smoke inhalation.
Main Methods:
- The abstract does not specify the methods used.
- Further research is needed to detail the experimental or observational approaches.
Main Results:
- Within the lungs, injury results from deposited particles and toxic gases from the burnt substrate.
- The inflammatory response is implicated as a direct cause of injury, potentially creating a feedback loop.
- Particulate matter and toxic fumes reflect the chemical composition of burnt substances, not solely carbon.
Conclusions:
- Smoke inhalation causes lung injury through particle deposition and toxic gas exposure, initiating an inflammatory cascade.
- Persistent particulate matter may lead to ongoing lung damage and impaired respiratory function in survivors.
- The chemical nature of the burnt material dictates the composition of inhaled toxins and particles, influencing injury severity.
Related Concept Videos
01:16The Respiratory System
The respiratory system is comprised of the organs that enable breathing. Air enters the nostrils and mouth, followed by the pharynx (throat) and larynx (voice box), which lead to the trachea (windpipe). In the thoracic cavity, the trachea splits into two bronchi that allow air to enter the lungs. The bronchi split into progressively smaller bronchioles and terminate in small groups of tiny sacs in the lungs called alveoli, where gas exchange occurs.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Inhaled Medications
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...